Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sanara MedTech Inc.

    NASDAQ: SMTI · Real-Time Price · USD
    28.75
    0.06 (0.21%)
    At close: Jun 13, 2025, 3:59 PM
    29.36
    2.10%
    After-hours: Jun 13, 2025, 04:09 PM EDT

    Sanara MedTech Statistics

    Share Statistics

    Sanara MedTech has 8.89M shares outstanding. The number of shares has increased by 3.21% in one year.

    Shares Outstanding

    n/a
    		 8.89M

    Shares Change (YoY)

    n/a
    		 3.21%

    Shares Change (QoQ)

    n/a
    		 1.84%

    Owned by Institutions (%)

    n/a
    		 11.19%

    Shares Floating

    n/a
    		 2.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 901

    FTD / Avg. Volume

    n/a
    		 3.01%

    Short Selling Information

    The latest short interest is 183.75K, so 2.07% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 183.75K

    Short % of Shares Out

    n/a
    		 2.07%

    Short % of Float

    n/a
    		 4.44%

    Short Ratio (days to cover)

    n/a
    		 6.77

    Valuation Ratios

    The PE ratio is -29.15 and the forward PE ratio is -20.65. Sanara MedTech's PEG ratio is -0.24.

    PE Ratio

    n/a
    		 -29.15

    Forward PE

    n/a
    		 -20.65

    PS Ratio

    n/a
    		 3.25

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 7.15

    P/FCF Ratio

    n/a
    		 -1226.64

    PEG Ratio

    n/a
    		 -0.24
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sanara MedTech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.82.

    Current Ratio

    n/a
    		 2.18

    Quick Ratio

    n/a
    		 2

    Debt / Equity

    n/a
    		 0.82

    Debt / EBITDA

    n/a
    		 -17.35

    Debt / FCF

    n/a
    		 -140.59

    Interest Coverage

    n/a
    		 -2.15

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $614,698.05

    Profits Per Employee

    n/a
    		 $-68,542.89

    Employee Count

    n/a
    		 141

    Asset Turnover

    n/a
    		 0.98

    Inventory Turnover

    n/a
    		 2.96

    Taxes

    Income Tax

    n/a
    		 247.35K

    Effective Tax Rate

    n/a
    		 -2.56%

    Stock Price Statistics

    The stock price has increased by -4.42% in the last 52 weeks. The beta is 1.33, so Sanara MedTech's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.33

    52-Week Price Change

    n/a
    		 -4.42%

    50-Day Moving Average

    n/a
    		 30.35

    200-Day Moving Average

    n/a
    		 32.87

    Relative Strength Index (RSI)

    n/a
    		 41.5

    Average Volume (20 Days)

    n/a
    		 29,942

    Income Statement

    In the last 12 months, Sanara MedTech had revenue of 86.67M and earned -9.66M in profits. Earnings per share was -1.14.

    Revenue

    n/a
    		 86.67M

    Gross Profit

    n/a
    		 78.53M

    Operating Income

    n/a
    		 -6.72M

    Net Income

    n/a
    		 -9.66M

    EBITDA

    n/a
    		 -1.86M

    EBIT

    n/a
    		 -6.78M

    Earnings Per Share (EPS)

    n/a
    		 -1.14
    Full Income Statement

    Balance Sheet

    The company has 15.88M in cash and 32.29M in debt, giving a net cash position of -16.41M.

    Cash & Cash Equivalents

    n/a
    		 15.88M

    Total Debt

    n/a
    		 32.29M

    Net Cash

    n/a
    		 -16.41M

    Retained Earnings

    n/a
    		 -37.78M

    Total Assets

    n/a
    		 59.54M

    Working Capital

    n/a
    		 23.56M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -23.78K and capital expenditures -205.85K, giving a free cash flow of -229.63K.

    Operating Cash Flow

    n/a
    		 -23.78K

    Capital Expenditures

    n/a
    		 -205.85K

    Free Cash Flow

    n/a
    		 -229.63K

    FCF Per Share

    n/a
    		 -0.03
    Full Cash Flow Statement

    Margins

    Gross margin is 90.61%, with operating and profit margins of -7.75% and -11.15%.

    Gross Margin

    n/a
    		 90.61%

    Operating Margin

    n/a
    		 -7.75%

    Pretax Margin

    n/a
    		 -11.15%

    Profit Margin

    n/a
    		 -11.15%

    EBITDA Margin

    n/a
    		 -2.15%

    EBIT Margin

    n/a
    		 -7.75%

    FCF Margin

    n/a
    		 -0.26%

    Dividends & Yields

    SMTI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SMTI is $49.5, which is 72.2% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $49.5

    Price Target Difference

    n/a
    		 72.2%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:100.

    Last Split Date

    n/a
    		 May 10, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:100

    Scores

    Altman Z-Score

    n/a
    		 4.06

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist